Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Neuroblastoma 2Wilms Tumor 1Testicular Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Medulloblastoma 1Familial ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Filgrastim 14Carboplatin 11Peripheral Blood Stem Cell Transplantation 9Ifosfamide 9Etoposide 8Flow Cytometry 5Thiotepa 4Therapeutics 4Paclitaxel 4Cyclophosphamide 4Cisplatin 4pegfilgrastim 3Temozolomide 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Melphalan 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3Busulfan 3sargramostim 2liposomal amphotericin B 2ixabepilone 2etoposide phosphate 2aldesleukin 2Topotecan 2Radiotherapy 2Ondansetron 2Methylprednisolone 2Magnetic Resonance Spectroscopy 2Itraconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Transplantation × CNS × Clear all
NCT00638898 2025-03-20

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

City of Hope Medical Center

Phase 1 Completed
25 enrolled
CNSGenitourinarySarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Testicular Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡